C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2006
11/07/2006	US7132253 lowered activity for N-ethylglycine; reagent for measuring creatinine or creatine
11/07/2006	US7132242 Method and device for targeted delivery of materials to selected single cells
11/07/2006	US7132241 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4
11/07/2006	US7132240 Obtaining chromosomal DNA from plants for preparing expression vectors comprising artificial chromosomes
11/07/2006	US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006	US7132099 Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
11/07/2006	CA2263954C Dehydrated food containing lactic acid bacteria
11/07/2006	CA2097523C Alkaline proteases from bacillus pumilus
11/02/2006	WO2006116657A2 Single-chain antibody with cleavable linker
11/02/2006	WO2006116487A2 Polypeptides and biosynthetic pathways for the production of monatin and its precursors
11/02/2006	WO2006116325A2 Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor
11/02/2006	WO2006115430A1 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein
11/02/2006	WO2006115426A1 Method for controlling biological processes and a device for carrying out said method
11/02/2006	WO2006115199A1 Method of treating wastewater containing organic compound
11/02/2006	WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006	WO2006114787A2 Wood-rotting basidiomycetes for production of ligninolytic enzymes
11/02/2006	WO2006114778A1 Probiotic composition suitable for animals
11/02/2006	WO2006114500A2 Method for producing strains of overproductive staphylococcus aureus
11/02/2006	WO2006114094A1 Arabinofuranosidases
11/02/2006	WO2006090212A3 Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants
11/02/2006	WO2006087405B1 Novel microalgal species and use thereof for animal and/or human consumption and in the production of carotenoids
11/02/2006	WO2006043178A3 Enzymes
11/02/2006	WO2005072262A3 Methods and compositions for evolving microbial hydrogen production
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248609 DNAs coding for flavone synthases, methods of using flavone synthase DNAs, and plants, flowers, and vectors containing flavone synthase DNAs
11/02/2006	US20060247421 Liver x receptor alpha splicing mutant protein, gene thereof and utilization of the same
11/02/2006	US20060247419 Translocation dependent complementation for drug screening
11/02/2006	US20060247316 Food supplement
11/02/2006	US20060247202 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/02/2006	US20060247196 Yeast genes that affect viral replication
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247164 Meltrins
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246590 Method of altering levels of plasmids
11/02/2006	US20060246581 Microorganism culturing apparatus and method of inserting bag into culturing apparatus
11/02/2006	US20060246570 Isolation and use of decay fungi
11/02/2006	US20060246562 A recombinant E. coli strain transformed with a copy of an exogenous gene encoding an enzyme having a glycerol dehydratase activity, exogenous genes encoding a protein having a 1,3-propanediol oxidoreductase, cob(I)alamin adenosyltransferase, glycerol dehydratase activity
11/02/2006	US20060246561 Adh from rhodococcus erythropolis
11/02/2006	US20060246560 Compositions and methods for manipulating carbon flux in cells
11/02/2006	US20060246559 Method for the production of p-hydroxybenzoate in species of Pseudomonas and agrobacterium
11/02/2006	US20060246554 Alleles of the gnd gene from coryneform bacteria
11/02/2006	US20060246552 Novel plasmid autonomously replicable in enterobacteriaceae family
11/02/2006	US20060246545 Gene inactivated mutants with altered protein production
11/02/2006	US20060246542 System for antibody expression and assembly
11/02/2006	US20060246541 eukaryotic proteins that require formation of disulfide bridges for biological activity; comprising a thioredoxin located N-terminal to the domain
11/02/2006	US20060246540 Monoclonal, humanized, fragmented or labeled antibodies; extracellular proteins; expression vectors; host cells
11/02/2006	US20060246539 Protein production method utilizing yebF
11/02/2006	US20060246519 For use in the capture and/or purification of biotinylated proteins
11/02/2006	US20060246515 High throughput generation and affinity maturation of humanized antibody
11/02/2006	US20060246509 Unnatural reactive amino acid genetic code additions
11/02/2006	US20060246504 Detection and treatment of polycystic kidney disease
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246481 Methods of identifying cellular target molecules
11/02/2006	US20060246471 Compositions and methods for screening pro-apoptotic compounds
11/02/2006	US20060246468 enzyme inhibitors; useful in the production of carbohydrate chains within glycoproteins/glycolipids; detecting, or inhibiting the production of, the alpha -1,3-fucosyltransferase which involves the use of cDNA coding the enzyme
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246417 System for functional analysis of polypeptides
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility
11/02/2006	US20060246049 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
11/02/2006	US20060246045 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concertration
11/02/2006	US20060246040 Deodorizing agent containing dry cell of microorganism as active ingredient and deodorizing method
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246028 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/02/2006	EP1717316A1 Interferon-like protein ZCYTO21
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1716240A1 Microbial production of vitamin c
11/02/2006	EP1716237A1 Orotate transporter encoding marker genes
11/02/2006	EP1716170A2 Hyphal growth in fungi
11/02/2006	EP1296636B1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1017822B1 Lkta deletion mutant of p. haemolytica
11/02/2006	EP1009834B1 Regulation of protein secretion
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	EP0784695B1 Method for preparing nucleic acids for analysis and kits useful therefor
11/02/2006	DE10329819B4 Verfahren zur extraktiven Isolierung von organischen Komponenten aus Zellsuspensionen und zellfreien Medien A process for the extractive isolation of organic components from cell suspensions and cell-free media
11/02/2006	DE102005018835A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung verbesserter Stämme der Familie Enterobacteriaceae A process for the preparation of L-amino acids using strains of the Enterobacteriaceae family improved
11/02/2006	CA2632353A1 Vaccine adjuvants comprising mycobaterium
11/02/2006	CA2606178A1 Polypeptides and biosynthetic pathways for the production of monatin and its precursors
11/02/2006	CA2605782A1 Arabinofuranosidases
11/02/2006	CA2605740A1 Method for producing strains of overproductive staphylococcus aureus
11/02/2006	CA2604786A1 Single-chain antibody with cleavable linker
11/01/2006	CN1856792A Method for determination of metabolic flux affecting production of useful material
11/01/2006	CN1856577A Biocatalyst for producing d-lactic acid
11/01/2006	CN1856575A DNA transfection system for the generation of infectious influenza virus
11/01/2006	CN1856569A Animal product free system and process for purifying a botulinum toxin
11/01/2006	CN1856568A Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract
11/01/2006	CN1856505A Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
11/01/2006	CN1854303A Method for the production of S-adenosylmethionine by fermentation
11/01/2006	CN1854301A Expression human seralbumin carrier and engineering bacterium
11/01/2006	CN1854299A Production of recombinant insulinum primary C peptide
11/01/2006	CN1854298A Chimeric gene with delta 6 fatty acid dehydrogenase function and its use
11/01/2006	CN1854296A Production of recombinant human interferon beta
11/01/2006	CN1854295A Production of specific micro-antibody for oarium cancer
11/01/2006	CN1854290A Rhodococcus erythropolis for biological desulfurization and its use

1 ... 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 ... 1489